Markets

Health Care Sector Update for 08/04/2015: ELGX, CPHR, REGN

A generic image of a stock chart.
Credit: Shutterstock photo

Top Health-care stocks:

JNJ: flat

PFE: flat

ABT: flat

MRK: flat

AMGN: +0.2%

Health-care shares were mainly unchanged in pre-market trade Tuesday.

In health-care stocks news, medical devices manufacturer Endologix ( ELGX ) shares were downgraded by Canaccord Genuity to hold from buy.

Shares in the company were unchanged pre-bell at $14.06. Over the past 52 weeks, the company has traded between $10.29 and $18.07.

Meanwhile, Cipher Pharmaceuticals ( CPHR ) says it has received an Acceptance Review Notification for its 510(k) submission for Dermadexin to the U.S. Food & Drug Administration.

Shares in the company were also flat pre-bell. Over the past 52 weeks, the company has traded between $7.74 and $18.

And Regeneron Pharmaceuticals ( REGN ) says Q2 non-GAAP EPS rose 17% to $2.89 from last year and topped the CapIQ mean for $2.78. Total sales were $999 million, above estimates for $887.59 million.

Shares in the company were trading 4.6% higher at $580 pre-bell. Over the past 52 weeks, the company has traded between $314 and $569.91.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ELGX REGN

Other Topics

Commodities